Latest round: IPO. Rahul Kakkar is a biotech entrepreneur and physician-scientist with nearly 20 years of experience founding and building biotechnology.
Rahul Kakkar is a biotech entrepreneur and physician-scientist with nearly 20 years of experience founding and building biotechnology companies and practicing medicine. He previously served as President and CEO of Tome Biosciences and CEO at Pandion Therapeutics, which successfully completed an IPO before its acquisition by Merck. Currently, he is a CEO-Partner at Flagship Pioneering and Chief Executive Officer of Quotient Therapeutics, while also practicing medicine at Brigham and Women's Hospital and lecturing at Harvard Medical School.
Full founder directory · Investor directory · Company funding database · Fundraising library